Innovative Eyewear Inc

Innovative Eyewear Inc(LUCY)股票分析

$0.828

+0.007 (+0.83%)收盘时

Loading chart…
最高
0.830
开盘
0.810
成交量加权均价
0.82
成交量
57.47K
市值
7.75M
最低
0.804
成交额
47.16K
企业价值/息税折旧摊销前利润(TTM)
-0.13

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications.

lucyd.co

AI 分析 of Innovative Eyewear Inc (LUCY)

持有

Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.

估值指标

Innovative Eyewear Inc(LUCY)当前预期市盈率为 0.00,5 年平均预期市盈率为 -1.42。

预期市盈率

高估
5 年均值 P/E
-1.42
当前P/E
0.00
高估
-0.38
低估
-2.45

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
2.71
当前EV/EBITDA
-0.13
高估
21.64
低估
-16.22

预期市销率

合理
5 年均值 P/S
4.02
当前P/S
0.33
高估
11.54
低估
-3.49

Alphio AI 对 LUCY 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%LUCY

$4.12

情景价格

基

基准

基准 · 50%LUCY

$3.43

情景价格

悲

悲观

悲观 · 25%LUCY

$2.04

情景价格

事件时间线

2026-10-06 (ET)

08:30:00

Innovative Eyewear Reports Q3 Net Sales of $1.04M

2026-09-08 (ET)

08:30:00

Innovative Eyewear Partners with Directed Electronics for Exclusive Distribution in Australia and New Zealand

2026-09-03 (ET)

08:30:00

Innovative Eyewear Reports Q3 2026 Revenue Surpassing $1M for the First Time

2026-08-24 (ET)

08:30:00

Innovative Eyewear Forms Strategic Alliance with HTC

08:00:00

Innovative Eyewear Launches Lucyd Armor Products in Major US Retailer

资讯

LUCY 常见问题 —— 由 Alphio AI 解答

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications. It operates in the Healthcare sector (OPHTHALMIC GOODS industry).

Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易